Skip to main content

Table 4 Summary of studies on cytoreductive surgery of recurrent endometrial cancer

From: Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study

  Case PFI (m) Surgery patients OS (m) Optimal definition (cm) Optimal cytoreduction (%) Optimal median OS (m) Suboptimal median OS (m)
Scarabelli [7] 20 16.9 20 NA No gross 65 (13/20) 12 Undefined
Campagnutta [8] 75 13 75 19 <=1 74.7 (56/75) 53 9
Bristow [9] 61 18.5 35 28 No grossly visible 65.7 (23/35) 39 13.5
/ 26 13 / / / /
Awtrey [10] 27 20 27 35 <=2 67 (18/27) 43 10
This study 75 18 75 18 <=1 77.3(58/75) 72 22
  1. Note. NA, not assessable. PFI, progression free interval. OS, overall survival.